Alessandro Curioni

Vice-President, Europe and Africa; Director, IBM Research Europe

Dr. Alessandro Curioni is an IBM Fellow, Vice President of IBM Europe and Africa and Director of the IBM Research Lab in Zurich, Switzerland. He is responsible for IBM corporate research in Europe and leads IBM's global research strategies in Accelerated Discovery and Security.

Dr. Curioni is an internationally recognized leader in the area of high-performance computing and computational science, where his innovative thinking and seminal contributions have helped solve some of the most complex scientific and technological problems in healthcare, aerospace, consumer goods and electronics. He was a member of the winning team recognized with the prestigious Gordon Bell Prize in 2013 and 2015. His research interests now include AI, Big Data and novel compute paradigms, such as neuromorphic and quantum computing.

Dr. Curioni received his undergraduate degree in Theoretical Chemistry and his PhD from Scuola Normale Superiore, Pisa, Italy. He started at IBM Research – Zurich as a PhD student in 1993 before officially joining as a research staff member in 1998, where he had several research and manager roles, including being the founding manager of the Cognitive Computing and Computational Sciences department. He is a member of the Swiss Academy of Technical Sciences

最热内容

为什么现在是建立量子数据中心的最佳时机?

虽然量子物理学概念可以追溯到几十年前,但量子计算研究在20世纪80年代和90年代还主要停留于理论层面。然而,时至21世纪,这项技术不仅已走出研究实验室,而且还能与经典方法(classical approach)等其他更为传统的计算方式形成互补。大大小小的多家公司以及学术界都在推动前沿研究,这使得量子比特(量子信息的基本单位)更加稳定,量子技术的应用规模也得到扩大。

2023年07月25日
健康与医疗系统

AIと量子コンピューティングで抗生物質耐性に挑む

世界が新型コロナウイルスのパンデミック(世界的大流行)から立ち直りつつある今、新たなグローバル課題が影を落としています。それは、抗生物質耐性による危機です。世界各地で人々がマスクを外し、日常に「ソーシャル・ミキシング」が戻りつつある中、風邪の症状でパニックになる人もいるかもしれませんが、やみくもに抗生物質を飲むことは解決策にはなりません。抗生物質を飲めば飲むほど、細菌は抗...

2022年09月28日

关于我们

加入我们

  • 登录
  • 成为我们的合作伙伴
  • 成为我们的会员
  • 订阅我们的新闻稿
  • 联系我们

快捷链接

语言版本

隐私政策和服务条款

站点地图

© 2025 世界经济论坛